| Trimodality PET/CT/MRI and radiotherapy: a mini-review P Decazes, P Hinault, O Veresezan, S Thureau, P Gouel, P Vera Frontiers in Oncology 10, 614008, 2021 | 59 | 2021 |
| Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma C Lemarignier, F Di Fiore, C Marre, S Hapdey, R Modzelewski, P Gouel, ... European journal of nuclear medicine and molecular imaging 41, 2008-2016, 2014 | 59 | 2014 |
| Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier P Desbordes, S Ruan, R Modzelewski, P Pineau, S Vauclin, P Gouel, ... PLoS One 12 (3), e0173208, 2017 | 55 | 2017 |
| FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer S Thureau, B Dubray, R Modzelewski, P Bohn, S Hapdey, S Vincent, ... Radiation oncology 13, 1-7, 2018 | 44 | 2018 |
| Advances in PET and MRI imaging of tumor hypoxia P Gouel, P Decazes, P Vera, I Gardin, S Thureau, P Bohn Frontiers in Medicine 10, 1055062, 2023 | 28 | 2023 |
| First comparison between [18F]-fmiso and [18F]-faza for preoperative pet imaging of hypoxia in lung cancer S Thureau, N Piton, P Gouel, R Modzelewski, A Dujon, JM Baste, J Melki, ... Cancers 13 (16), 4101, 2021 | 22 | 2021 |
| Impact of the Bayesian penalized likelihood algorithm (Q. Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images E Texte, P Gouel, S Thureau, J Lequesne, B Barres, A Edet-Sanson, ... EJNMMI physics 7, 1-15, 2020 | 13 | 2020 |
| Does enhanced CT influence the biological GTV measurement on FDG-PET images? P Vera, R Modzelewski, S Hapdey, P Gouel, H Tilly, F Jardin, S Ruan, ... Radiotherapy and Oncology 108 (1), 86-90, 2013 | 10 | 2013 |
| Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [18F]FDG and [18F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients S Thureau, R Modzelewski, P Bohn, S Hapdey, P Gouel, B Dubray, ... Molecular Imaging and Biology 22, 764-771, 2020 | 9 | 2020 |
| Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F] FDG-PET tumour residual uptake … P Vera, S Thureau, F Le Tinier, P Chaumet-Riffaud, S Hapdey, ... The Lancet Oncology 25 (9), 1176-1187, 2024 | 8 | 2024 |
| Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation J Ganem, S Thureau, P Gouel, B Dubray, M Salaun, E Texte, P Vera PLoS One 14 (10), e0222885, 2019 | 8 | 2019 |
| Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients S Hapdey, A Edet-Sanson, P Gouel, B Martin, R Modzelewski, M Baron, ... Radiotherapy and Oncology 112 (3), 407-412, 2014 | 8 | 2014 |
| Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study P Gouel, F Callonnec, É Levêque, C Valet, A Blôt, C Cuvelier, S Saï, ... Scientific Reports 13 (1), 9148, 2023 | 5 | 2023 |
| Quantitative MRI to characterize hypoxic tumors in comparison to FMISO PET/CT for radiotherapy in oropharynx cancers P Gouel, F Callonnec, FR Obongo-Anga, P Bohn, E Lévêque, ... Cancers 15 (6), 1918, 2023 | 4 | 2023 |
| Synthetic MRI for radiotherapy planning for brain and prostate cancers: phantom validation and patient evaluation P Gouel, S Hapdey, A Dumouchel, I Gardin, E Torfeh, P Hinault, P Vera, ... Frontiers in Oncology 12, 841761, 2022 | 4 | 2022 |
| How to work together between nuclear medicine and radiotherapy departments? R Modzelewski, D Gensanne, S Hapdey, P Gouel, P Vera, S Thureau Cancer/Radiothérapie 24 (5), 358-361, 2020 | 4 | 2020 |
| Définition des volumes cibles: quand et comment l’oncologue radiothérapeute peut-il utiliser la TEP? S Thureau, E Texte, P Decazes, D Gensanne, P Gouel, R Modzelewski, ... Cancer/Radiothérapie 23 (6-7), 745-752, 2019 | 4 | 2019 |
| " Definition of target volume: When et how can the radiation oncologist use PET?" S Thureau, P Decazes, D Gensanne, P Gouel, R Modzelewski, S Hapdey, ... Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie …, 2019 | 2 | 2019 |
| Mise en place de la trimodalité appliquée à la radiothérapie D Gensanne, P Gouel, P Decazes, AE Sanson, F Callonnec, D Defta, ... Médecine Nucléaire 43 (2), 214-215, 2019 | 2 | 2019 |
| Characterization of positioning uncertainties in PET‐CT‐MR trimodality solutions for radiotherapy P Hinault, I Gardin, P Gouel, P Decazes, S Thureau, O Veresezan, ... Journal of Applied Clinical Medical Physics 23 (7), e13617, 2022 | 1 | 2022 |